LumiThera, Inc.
Clinical trials sponsored by LumiThera, Inc., explained in plain language.
Now part of
Alcon Inc.
ALC
NYSE
A medical device company developing photobiomodulation therapy for eye diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.